Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) will likely be announcing its earnings results on Monday, March 17th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $2.70 million for the quarter.
Pharma-Bio Serv Price Performance
Shares of PBSV opened at $0.55 on Friday. Pharma-Bio Serv has a 12-month low of $0.31 and a 12-month high of $0.90. The firm has a market capitalization of $12.61 million, a PE ratio of -18.33 and a beta of 0.53. The stock’s fifty day simple moving average is $0.55 and its 200-day simple moving average is $0.57.
Pharma-Bio Serv Dividend Announcement
The business also recently announced a dividend, which will be paid on Thursday, March 20th. Shareholders of record on Friday, February 28th will be paid a $0.075 dividend. The ex-dividend date is Friday, February 28th. Pharma-Bio Serv’s payout ratio is -250.00%.
Pharma-Bio Serv Company Profile
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Read More
- Five stocks we like better than Pharma-Bio Serv
- 5 Top Rated Dividend Stocks to Consider
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Using the MarketBeat Stock Split Calculator
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.
